It will attract quacks like shit attracts flies, so yes, of course there are limits: New treatments need to be more effective or cheaper for some well-defined ailment to end up on the approved list. If they're very expensive, they might not be first in line (but still available for patients where the case can be made that they need it). That can be frustrating, but shouldn't be life threatening.
Experimental treatments are research. Their test subjects are picked by a schedule that is unrelated to medical care needs but optimizes for good data acquisition. Pay for them from research budgets, not health care.
Is there a public example of a rich person that 'beat' cancer this way?
The option is open to anyone who is rich, and if you have an slow incurable cancer it is reasonable to try: you don't have anything to lose and it might work. Of course if your cancer is already curable focus on the existing cure. If the cancer is fast you don't have enough time to for research to produce results. At best it is a long shot, but it is what you have.
If you are young and healthy you actually have a better chance of your small donation making a difference. Just figure out what cancer you are at risk for and start regular donations to that research now. While your donation alone won't do much, the regular source of income helps those already doing the research keep going for the years required to get results. Your smaller donation along with others goes farther because time is a factor. The only problem is which: the cancer mom's mom had, the cancer dad's mom had, the cancer mom's brother had, the non-hereditary cancer both dad's brother and sister had, the cancer someone else in the family will get in two years?
A good example is the cbc.ca article where two friends were diagnosed with the same cancer. The one in the US got treated with the latest cancer drug and is remission, where the woman living in Canada has to sell her house to pay for it.[1]
"It's crazy that I live in Canada, but now I'm looking at having to sell my house for coverage of my medication."
[1]https://www.cbc.ca/news/canada/british-columbia/a-tale-of-2-...
We have very good evidence that these new, expensive, treatments do not extend life and that they make quality of life worse.
England set up something called the Cancer Drugs Fund. This provided access to new medication that hadn't yet been assessed for value; that were in the process of being assessed; or that had been assessed and were found to be too expensive for no benefit over existing treatment: https://en.wikipedia.org/wiki/Cancer_Drugs_Fund
Most drugs paid for by £1.27bn Cancer Drugs Fund had no “meaningful benefit” https://www.bmj.com/content/357/bmj.j2097
The Cancer Drugs Fund was popular with the UK press who pushed for it to be expanded without bothering to see if it was extending life or improving quality of life. http://journals.sagepub.com/doi/full/10.1177/014107681879680...
> Health care already is 17% of the US GDP and the US government spends more % of GDP on healthcare in America than almost all European countries.
And yet it has worse outcomes across a range of measures, including "life expectancy".
It's not pushing any myth at all. As explained elsewhere government-run systems like the NHS do attach actual dollar amounts to treatments that are effective and do extend life, but for which they're not willing to pay.
The NHS's version is actually quite ruthless when you peel back the details, where they determine how "good" a person's life is, and essentially how much they are willing to spend to extend that person's life by N years. This is, in effect, a benefits cap, just framed slightly differently.
This is not, as you are implying, saying "this treatment is ineffective or harmful, so we won't pay for it". It is literally saying "we understand that this treatment would extend this person's life by 5 years, but it costs £50,000, and based on their condition, we're only willing to spend £25,000 to extend their life by 5 years.
> And yet it has worse outcomes across a range of measures, including "life expectancy".
Life expectancy has so many confounding variables which have a much stronger effect that it's ridiculous to try and use that as a measure of a healthcare system directly. It's like trying to measure the fuel efficiency of different models of cars by looking at the total number of miles driven by all drivers of each car model in a given year. Yeah, there's... a connection between the two, but that's certainly not what you're analyzing when you try to compare them naively.
No they don't. This is not true.
> This is not, as you are implying, saying "this treatment is ineffective or harmful, so we won't pay for it". It is literally saying "we understand that this treatment would extend this person's life by 5 years, but it costs £50,000, and based on their condition, we're only willing to spend £25,000 to extend their life by 5 years.
This is just not true. Find just one single medication that i) extends life by 5 years ii) costs just £10,000 per year and iii) has been banned.
That is literally what QALY is.
> Find just one single medication that i) extends life by 5 years ii) costs just £10,000 per year and iii) has been banned.
It seems like you don't understand how coverage works for cancer treatment. The question isn't whether the medication is banned outright - it's whether it will be approved to be used for a specific patient in their treatment plan (paid for by the NHS).
Please tell me how you think cancer drug funding works in England, because I'm pretty sure you're wrong.
But let's assume for the moment that you're right: please link to an article about a patient who would have been kept alive for 5 years if they'd been given treatment but they were denied the treatment because it cost more than £50,000.
If anything the UK was spending too much on cancer drugs that provided no benefit - no extension of life, combined with unpleasant side effects that lowered quality of life.
https://www.newscientist.com/article/dn26785-the-uks-cancer-...
Just to be clear: you're telling me that you think QALY calculations are not factored into the decisions of which treatments will be covered for an individual cancer patient under the NHS?
It’s like using average salary as a measure of how intelligent someone is.
Is there a correlation? Sure, but a weak one and many other factors impact it.
Once you've made it past your 20s, life expectancy in the US is quite good.
When you look at different causes of death (diseases of the circulatory system, neoplasm, disease of respiratory system, external causes, mental and behavioural, diseases of the nervous system, and endocrine nutritional and metabolic disease) the US does worse than average on every single one of them apart from cancer.
https://www.healthsystemtracker.org/chart-collection/mortali...
> The U.S. has the highest rate of deaths amenable to health care among comparable countries
> Researchers have looked at mortality that results from medical conditions for which there are recognized health care interventions that would be expected to prevent death. While the health care system might not be expected to prevent death in all of these instances, differences in mortality for these conditions provides information about how effectively health care is being delivered. In 2006, the last year for which reasonably complete information is available, the U.S. had the highest mortality rate for deaths amenable to health care among the comparable countries.
Everyone can't get the best possible care unless those experimental and expensive procedures are just banned and we give up on expensive procedures becoming cheaper in the future. Cancer is the biggest reason for this. If you have a cancer and can afford to employ a small research team for a few million a year, your chances them finding a custom way to beat it is much better than just trying to select from the existing treatments already out there. Health care already is 17% of the US GDP and the US government spends more % of GDP on healthcare in America than almost all European countries.
Not sure the best way to a better health care system in the USA, but just uncapping how much can be spent under insurance plans, while fixing one problem, won't work in the long run (as we are already seeing).